Related Experiment Video
Updated: Jul 20, 2025
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.6K
A Web-Based Application for Risk Stratification and Optimization in Patients With Cardiovascular Disease: Pilot Study
Avinash Pandey1,2, Marie Michelle D'Souza2, Amritanshu Shekhar Pandey2,3
1Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
JMIR Cardio
|August 3, 2023
Summary
The Stratification and Optimization in Patients With Cardiovascular Disease (STOP-CVD) application is a feasible and usable tool for improving secondary prevention therapy uptake in cardiovascular disease patients, showing high clinician satisfaction.
Area of Science:
- Cardiology
- Digital Health
- Clinical Informatics
Background:
- Novel therapies improve outcomes in atherosclerotic cardiovascular disease (ASCVD) but face challenges in uptake.
- Knowledge translation strategies are needed to enhance secondary prevention therapy adoption.
- Individualized risk stratification and guidance can support guideline-directed therapy.
Purpose of the Study:
- To test the feasibility and usability of the Stratification and Optimization in Patients With Cardiovascular Disease (STOP-CVD) application.
- To evaluate STOP-CVD's role in facilitating knowledge translation for secondary prevention.
- To assess clinician experience with a point-of-care risk stratification and optimization tool.
Main Methods:
- A free, web-based secondary risk calculator was developed using the REACH Registry trial data (67,888 patients).
- The application predicted 20-month cardiovascular event/mortality risk and identified modifiable residual risk.
- Physicians received invitations; user experience surveys and Google Analytics data were collected postimplementation.
Main Results:
- During a 1-year pilot, 47 of 240 invited clinicians used the STOP-CVD application 1573 times.
- Sustained usage averaged 131 uses per month.
- All 24 survey respondents found the application functional, easy to use, and useful.
Conclusions:
- The STOP-CVD application demonstrates feasibility, usability, and high clinician satisfaction.
- This tool can be scaled to support guideline-directed medical therapy uptake.
- Future research will assess the impact on clinical management and patient outcomes.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:26Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
01:21Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20